Inventor
LAI CHIAJEN
US17 patents
⚠️ This page may combine multiple inventors who share the name “LAI CHIAJEN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
8 patentsUS7919598B2Apr 5, 2011
Crystal structures of SGLT2 inhibitors and processes for preparing same
BRISTOL MYERS SQUIBB CO51 citations95
US7375213B2May 20, 2008
Methods of producing C-aryl glucoside SGLT2 inhibitors
BRISTOL MYERS SQUIBB CO123 citations95
US7932379B2Apr 26, 2011
Methods of producing C-aryl glucoside SGLT2 inhibitors
BRISTOL MYERS SQUIBB CO26 citations90
US7601715B2Oct 13, 2009
Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
BRISTOL MYERS SQUIBB CO4 citations58
US7671199B2Mar 2, 2010
Process for the preparation of [(1R), 2S]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2, 1-F][1,2,4]triazin-6-yloxy]-1-methylethyl ester
BRISTOL MYERS SQUIBB CO2 citations55
US7968718B2Jun 28, 2011
Process for preparing triazole substituted azaindoleoxoacetic piperazine derivatives and novel salt forms produced therein
BRISTOL MYERS SQUIBB CO0 citations48
US7820820B2Oct 26, 2010
Method of preparation of azaindole derivatives
BRISTOL MYERS SQUIBB CO0 citations46
US7598380B2Oct 6, 2009
Method of preparation of azaindole derivatives
BRISTOL MYERS SQUIBB CO0 citations46
GILEAD SCIENCES INC
5 patentsUS11613553B2Mar 28, 2023
Methods of preparing 1′-cyano nucleosides
GILEAD SCIENCES INC19 citations89
US11440928B2Sep 13, 2022
Crystalline forms of tenofovir alafenamide
GILEAD SCIENCES INC1 citations72
US10287307B2May 14, 2019
Crystalline forms of tenofovir alafenamide
GILEAD SCIENCES INC2 citations72
US12202849B2Jan 21, 2025
Crystalline forms of tenofovir alafenamide
GILEAD SCIENCES INC0 citations62
US10407438B2Sep 10, 2019
Crystalline forms of darunavir
GILEAD SCIENCES INC0 citations52
KRONOS BIO INC
2 patentsUS12152037B2Nov 26, 2024
Crystalline succinate salt of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as a Syk inhibitor
KRONOS BIO INC1 citations56
US11339168B2May 24, 2022
Crystalline forms of 6-(6-aminopyrazin-2-yl)-N-(4-(4-(oxetan-3-yl)piperazin-1-yl)phenyl)imidazo[1,2-a]pyrazin-8-amine as Syk inhibitors
KRONOS BIO INC1 citations56